| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K99584050 | CTRPv2 | pan-cancer | AAC | -0.037 | 0.5 |
| mRNA | Sorafenib | FIMM | pan-cancer | AAC | 0.12 | 0.5 |
| mRNA | BRD-K27224038 | CTRPv2 | pan-cancer | AAC | 0.05 | 0.5 |
| mRNA | Pazopanib | GDSC1000 | pan-cancer | AAC | -0.024 | 0.5 |
| mRNA | TGX221 | GDSC1000 | pan-cancer | AAC | -0.033 | 0.5 |
| mRNA | AZD7762 | CTRPv2 | pan-cancer | AAC | -0.023 | 0.5 |
| mRNA | BRD-K64610608 | CTRPv2 | pan-cancer | AAC | -0.027 | 0.5 |
| mRNA | ibrutinib | CTRPv2 | pan-cancer | AAC | -0.03 | 0.5 |
| mRNA | AMG-706 | FIMM | pan-cancer | AAC | 0.12 | 0.5 |
| mRNA | BRD-K35604418 | CTRPv2 | pan-cancer | AAC | -0.026 | 0.5 |